Structure |
Chemical Name |
CAS |
MF |
|
Captopril IMpurity H |
205521-07-9 |
C15H23NO5S2 |
|
Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) |
178949-04-7 |
C13H15N5O4S2 |
|
Ceftriaxone IMpurit D |
|
|
|
Ciprofloxacin Related CoMpound |
528851-30-1 |
C15H17Cl2N3O3 |
|
Dasatinib IMpurity 4 |
|
|
|
Deferasirox Methyl Ester |
1266741-05-2 |
C22H17N3O4 |
|
Deltacortinene Acetate (Predisolone Acetate IMpurity) |
4380-55-6 |
C23H28O5 |
|
Entecavir IMpurity A |
|
|
|
Fasudil IMpurity 1 |
1423155-03-6 |
C14H17N3O2S |
|
Irbesartan IMpurity |
1079997-01-5 |
C26H30N6O2 |
|
Montelukast EP IMpurity I |
|
|
|
RaceMic Fudosteine HCl |
1023971-15-4 |
C6H13NO3S |
|
RocuroniuM BroMide IMpurity 18 |
|
|
|
SalMeterol IMpurity E |
|
C25H37NO4 |
|
SulbactaM IMpurity C |
|
|
|
Terazosin IMpurity J |
152551-75-2 |
C19H27N5O4 |
|
Ticarcillin SodiuM IMpurity A |
36041-93-7 |
C14H16N2O4S2 |
|
EthanediaMide iMpurity E |
|
C2H4N2O2 |
|
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate |
1206875-41-3 |
C15H22N2O2 |
|
S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine |
889443-69-0 |
C11H17NO |
|
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide |
855860-75-2 |
C9H11ClN2O |
|
Ibrutinib iMpurity |
936351-48-3 |
C12H13ClN2O |
|
1-Phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one |
381725-50-4 |
C16H12N2O |
|
(1R,5S,6R)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester |
347378-74-9 |
C14H22O4 |
|
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid CalciuM Salt |
254452-96-5 |
C25H24FNO4 |
|
(αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide |
947723-87-7 |
C15H13N3O6S |
|
1-[[2-[(2-AMinophenyl)aMino]-5-Methyl-3-thienyl]carbonyl]-4-Methyl-piperazine |
138564-61-1 |
C17H22N4OS |
|
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester |
452092-31-8 |
C15H13F2NO4 |
|
2-(IsopropylaMino)-2',6'-acetoxylidide Hydrochloride |
35891-87-3 |
C13H21ClN2O |
|
2,2'-IMinobis(N-(2,6-DiMethylphenyl)acetiaMide Hydrochloride |
1135231-62-7 |
C20H26ClN3O2 |
|
3,4-O-(DiethylMethylidene) ShikiMic Acid Ethyl Ester |
943515-58-0 |
C14H22O5 |
|
4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol |
94749-02-7 |
C23H33NO4 |
|
5-[2-Ethoxy-5-[(4-Methyl-1-piperazinyl)thioxoMethyl]phenyl]-1,6-dihydro-1-Methyl-3-propyl-7H-pyrazolo[4,3-d]pyriMidine-7-thione |
1333233-46-7 |
C23H30N6OS2 |
|
BIRG 613 BS |
287980-85-2 |
C15H16N4O |
|
Deferasirox Salicyloyl Ester |
1395346-28-7 |
C28H19N3O6 |
|
N-2-Hydroxy-3-[[2-(Methoxyphenoxy)ethyl]aMine Carvedilol |
1198090-73-1 |
C36H43N3O7 |
|
Ticagrelor IMpurity B |
|
|
|
CitalopraM carboxylic acid iMpurity |
440121-09-5 |
C20H22FNO3 |
|
Decitabine iMpurity 6 |
178671-74-4 |
C7H14N4O4 |
|
DiazepaM IMpurity E |
20927-53-1 |
C15H11ClN2O |
|
ErtapeneM Side Chain EnantioMer 2 HCl |
503607-49-6 |
C12H15ClN2O3S |
|
Ribavirin IMpurity G |
|
|
|
Ethanone, 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone,1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone |
1157938-97-0 |
C10H7F2N3O |
|
3-Fluoro-4-phenylphenol |
477860-13-2 |
C12H9FO |
|
Heptyl Deoctyl FingoliMod Hydrochloride |
162361-44-6 |
C18H32ClNO2 |
|
4-Methoxy-3,5-diMethylpyridine 1-Oxide |
91219-89-5 |
C8H11NO2 |
|
N-Ethyl-3-buteno-o-toluidide |
13936-71-5 |
C13H17NO |
|
Pramipexole Impurity 21 |
104617-86-9 |
C10H17N3S |
|
Tigecycline Pentacyclic Analog |
1268494-40-1 |
C27H32N4O9 |
|
Tigecycline (open C-ring D-ring) Quinone |
1268494-46-7 |
C26H32N4O8 |
|
Pazopanib iMpurity |
|
|
|
Acetic acid, 2-[2-[2-[4-[(4- chlorophenyl)phenylMethyl]-1-piperazinyl]ethoxy]ethoxy]- |
682323-77-9 |
C23H29ClN2O4 |
|
edaravone iMpurity |
|
|
|
(2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C24H25FO5S |
|
5-(4-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
|
Ganciclovir EP Impurity H |
84222-50-4 |
C9H13N5O4 |
|
2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine |
97151-10-5 |
C24H25NO |
|
[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid] |
65134-74-9 |
C8H14O4S2 |
|
(E)-1-(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)ethanone |
935272-10-9 |
C18H20N4OS |
|
2-(thiophen-3-yl)ethyl 4-methylbenzenesulfonate |
40412-09-7 |
C13H14O3S2 |
|
4-Nitrophenyl 5-chlorothiophene-2-carboxylate |
1450877-56-1 |
C11H6ClNO4S |
|
Olaparib iMpurity B |
|
|
|
Posaconazole iMpurity 6 |
2185472-85-7 |
C30H35N5O3 |
|
Everolimus Isomer C |
|
|
|
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib |
1603814-04-5 |
C22H24ClFN4O3 |
|
Brivaracetam (Racemate) |
357335-87-6 |
C11H20N2O2 |
|
Donepezil Impurity 2 |
36517-91-6 |
C11H10O4 |
|
Fesoterodine Related Impurity 2 |
1254942-29-4 |
C30H39NO6 |
|
Prasugrel Impurity 13 HCl |
1618108-01-2 |
C18H19ClFNOS |
|
Ticagrelor Related Compound 5 |
1414348-35-8 |
C9H9F2N |
|
Vortioxetine Impurity 2 |
1293489-69-6 |
C17H20N2S |
|
(S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid |
1151893-81-0 |
C24H21Cl2N3O7S2 |
|
Cilastatin ammonium salt |
877674-82-3 |
C16H29N3O5S |
|
ACETIC ACID 2-METHOXY-4-(5-OXO-2-PHENYL-OXAZOL-4-YLIDENEMETHYL)-PHENYL ESTER |
18692-68-7 |
C19H15NO5 |
|
1,4-di(benzo[b]thiophen-4-yl)piperazine |
1420987-86-5 |
C20H18N2S2 |
|
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-52-4 |
C23H29NO4 |
|
DONEPEZIL IMP |
923571-16-8 |
C24H22NO4.Cl |
|
Parecoxib Impurity N |
|
|
|
5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
87475-54-5 |
C18H25Cl2N3O2 |
|
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
85-63-2 |
C21H27NO4 |
|
Linagliptin Impurity P |
|
|
|
Linagliptin Impurity U |
|
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid |
1917324-15-2 |
C18H21FN4O4 |
|
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide |
|
C40H42F2N10O6 |
|
ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
618385-10-7 |
C29H33FN2O4 |
|
(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate |
1621160-31-3 |
C20H18ClFO5 |
|
Etoricoxib Impurity 17 |
|
|
|
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
|
Imatinib Impurity 2 |
1384131-91-2 |
C7H11NO |
|
Mirabegron M5 (YM-538852) |
1365244-63-8 |
C18H22N2O2 |
|
Sofosbuvir Impurity 6 |
|
|
|
Vonoprazan Impurity 2 |
881733-36-4 |
C17H16FN3O2S |
|
Atomoxetine EP impurity A |
56161-70-7 |
C16H19NO |
|
Cinacalcet Impurity 21 |
|
|
|
Dasatinib Impurity D |
|
|
|
Doxofylline Impurity 1 |
1429636-74-7 |
C10H16N4O3 |
|
Isopropyl4-hydroxy-3,5-diisopropylbenzoate |
2095678-97-8 |
C16H24O3 |
|
Sitagliptin EP Impurity B |
1345822-87-8 |
C16H19F5N5O5P |
|
Trospium Impurity |
|
|
|
Vildagliptin Related Compound A |
741657-02-3 |
C17H25N3O |